Number of patients served annually (billion patients)

Number of employees (employees)

Number of manufacturing and packaging sites (sites)

Number of countries and territories served (countries and territories)

d12ae6d4f005ada732b6bc02510174a8d1b08fcfe4fead4d4465b0b13af3186e

Total Revenue [USD, Millions]

Cost of Goods Sold (COGS) [USD, Millions]

SG&A [USD, Millions]

R&D [USD, Millions]

D&A [USD, Millions]

Interest Expense [USD, Millions]

Operating Income (EBIT) [USD, Millions]

Net Income [USD, Millions]

EPS - Basic [USD]

EPS - Diluted [USD]

1a655ddfcfd168f696a8603c524123a0969215837076df0e1f275b471c5bc915

6c7dd3e17e7b5d4c6e4d7350d7a85fbf6f70710af00b5a1649bc9ef0a2123f3f

Developed Markets

Greater China

JANZ

Emerging Markets

- United States

- China

Total Net Sales

Total Revenue

c559a63a6456c742b6b3eef33f86bd9b68fd01049016779c7f0f2c951d09cad7

Brands

Generics

- Developed Markets

- Greater China

- JANZ

- Emerging Markets

Complex Generics (Complex Gx)

a86cb04dddebc8b0de4d643fdd6bc0ac2bdbb85588e11c6628f43e5f4a14a46b

Cash and Cash Equivalents (USD, millions)

Accounts Receivable, Net (USD, millions)

Inventories (USD, millions)

Prepaid Expenses and Other Current Assets (USD, millions)

Assets Held for Sale (USD, millions)

Total Current Assets (USD, millions)

Property, Plant and Equipment, Net (USD, millions)

Intangible Assets, Net (USD, millions)

Goodwill (USD, millions)

Deferred Income Tax Benefit (USD, millions)

Other Assets (USD, millions)

Total Assets (USD, millions)

Accounts Payable (USD, millions)

Income Taxes Payable (USD, millions)

Current Portion of Long-Term Debt and Other Long-Term Obligations (USD, millions)

Liabilities Held for Sale (USD, millions)

Other Current Liabilities (USD, millions)

Total Current Liabilities (USD, millions)

Long-Term Debt (USD, millions)

Deferred Income Tax Liability (USD, millions)

Other Long-Term Obligations (USD, millions)

Total Liabilities (USD, millions)

Common Stock (USD, millions)

Additional Paid-In Capital (USD, millions)

Retained Earnings (USD, millions)

Accumulated Other Comprehensive Loss (USD, millions)

Treasury Stock (USD, millions)

Total Equity (USD, millions)

Total Liabilities and Equity (USD, millions)

af3533b572af0c24cd4b6cb477e20aebe27c3c63dd60b3fc8b4a15ad26ec507a

Net Sales (USD, millions)

Other Revenues (USD, millions)

Total Revenues (USD, millions)

Cost of Sales (USD, millions)

Gross Profit (USD, millions)

Research and Development Expenses (USD, millions)

Acquired IPR&D (USD, millions)

Selling, General and Administrative Expenses (USD, millions)

Litigation settlements and other contingencies, net (USD, millions)

Total Operating Expenses (USD, millions)

Earnings (Loss) from Operations (USD, millions)

Interest Expense (USD, millions)

Other Income (Expense), Net (USD, millions)

Earnings (Loss) Before Income Taxes (USD, millions)

Income Tax (Benefit) Provision (USD, millions)

Net Earnings (Loss) (USD, millions)

Basic Earnings (Loss) per Share (USD)

Diluted Earnings (Loss) per Share (USD)

Weighted Average Shares Outstanding - Basic (Millions)

Weighted Average Shares Outstanding - Diluted (Millions)

57db373084c0ea3535ba171b97bfcb8c2b18b8197e2316d79befcafefba5f566

Adjustments for Non-Cash Items

Stock-Based Compensation

Changes in Working Capital

Capital Expenditures (CapEx)

Proceeds from / Repayments of Debt

Share Repurchases

Dividend Payments

Net Change in Cash

68b04869c1de80e3f1fe671e4ec4d5f0d28d5cfd4782b88e485a17c84a580bd7

Current Assets [USD, Millions]

Cash and Cash Equivalents [USD, Millions]

Accounts Receivable [USD, Millions]

Inventory [USD, Millions]

Non-Current Assets [USD, Millions]

Property, Plant, and Equipment (PP&E) [USD, Millions]

Goodwill [USD, Millions]

Intangible Assets [USD, Millions]

Current Liabilities [USD, Millions]

Accounts Payable [USD, Millions]

Short-term Debt [USD, Millions]

Accrued Expenses [USD, Millions]

Non-Current Liabilities [USD, Millions]

Long-term Debt [USD, Millions]

Lease Liabilities [USD, Millions]

Deferred Tax Liabilities [USD, Millions]

Shareholders' Equity [USD, Millions]

Retained Earnings [USD, Millions]

Common Stock [USD, Millions]

Additional Paid-in Capital [USD, Millions]

9462d87d73fa58e00afdc33fe56127db938a2f6548a396038201ea0de5e0c831

Viatris Inc (VTRS)

Financials